Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Clinical trial NCT07007312 · RECRUITING

Trial details

NCT number: NCT07007312
Sponsor: Kura Oncology, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)

Start date: 2025-09-26
Primary completion: 2031-11-01
Enrollment: 1300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.